BCRX icon

BioCryst Pharmaceuticals
BCRX

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$23
157% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
RBC Capital
RBC Capital
Brian Abrahams
50% 1-yr BCRX win rate
30 Jan ‘26 29 days ago
HC Wainwright & Co
HC Wainwright & Co
Andrew Fein
50% 1-yr BCRX win rate
15 Dec ‘25 2 months ago